Antisense Oligonucleotide-Mediated Terminal Intron Retention of the SMN2 Transcript
The severe childhood disease spinal muscular atrophy (SMA) arises from the homozygous loss of the survival motor neuron 1 gene (SMN1). A homologous gene potentially encoding an identical protein, SMN2 can partially compensate for the loss of SMN1; however, the exclusion of a critical exon in the cod...
Saved in:
Main Authors: | Loren L. Flynn (Author), Chalermchai Mitrpant (Author), Ianthe L. Pitout (Author), Sue Fletcher (Author), Steve D. Wilton (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficient SMN Rescue following Subcutaneous Tricyclo-DNA Antisense Oligonucleotide Treatment
by: Valérie Robin, et al.
Published: (2017) -
Antisense Oligonucleotide Mediated Splice Correction of a Deep Intronic Mutation in OPA1
by: Tobias Bonifert, et al.
Published: (2016) -
Mismatched single stranded antisense oligonucleotides can induce efficient dystrophin splice switching
by: Kole Ryszard, et al.
Published: (2011) -
Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics
by: Bao T. Le, et al.
Published: (2019) -
Corrigendum to "Antisense Oligonucleotide Mediated Splice Correction of a Deep Intronic Mutation in OPA1"
Published: (2016)